ÜberblickChartProfilKennzahlenBilanzNachrichten
Derivate
TraderScreen

Idorsia Ltd/  CH0363463438  /

Cboe Europe BXE
07.06.2024  17:00:59 Diff. +0,05 Volumen Geld17:20:00 Brief17:20:00 Marktkapitalisierung Dividendenr. KGV
2,31CHF +2,30% 24.944
Umsatz: 56.247,35		 -Geld Vol: - -Brief Vol: - -CHF - -
dpa-AFX 03.06 GNW-Adhoc: New data with daridorexant to be presented at SLEEP 2024
dpa-AFX 31.05 GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of ...
dpa-AFX 23.05 GNW-Adhoc: Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders
dpa-AFX 21.05 GNW-Adhoc: Idorsia announces changes to Idorsia Executive Committee and Board of Directors
dpa-AFX 21.05 GNW-Adhoc: Idorsia announces financial results for the first quarter 2024 - advancing the company wi...
dpa-AFX 21.05 GNW-Adhoc: Idorsia announces financial results for the full year of 2023 - Adapting the company to c...
dpa-AFX 14.05 GNW-Adhoc: Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and confer...
dpa-AFX 06.05 GNW-Adhoc: Bondholders approve amended terms of the 2024 convertible bonds
dpa-AFX 01.05 GNW-Adhoc: Idorsia increases the consent fee in connection with the proposed restructuring of the 20...
dpa-AFX 26.04 GNW-Adhoc: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant ...
dpa-AFX 23.04 GNW-Adhoc: Idorsia publishes an invitation to a bondholder meeting
dpa-AFX 17.04 GNW-Adhoc: Idorsia publishes a Financial Status required for an upcoming bondholder meeting
dpa-AFX 11.04 GNW-Adhoc: Idorsia takes steps to address short-term liquidity needs
APA/dpa-AFX 22.03 GNW-Adhoc: Idorsia thanks Guy Braunstein for his years of service as he retires
dpa-AFX 20.03 ROUNDUP/Aktien Europa Schluss: Moderate Verluste vor US-Zinsentscheid
dpa-AFX 20.03 Aktien Europa: Verluste vor US-Zinsentscheid - Kering belastet Luxusgüterbranche
dpa-AFX 20.03 GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) - the first and only endotheli...
dpa-AFX 18.03 GNW-Adhoc: Idorsia and Viatris successfully close the transaction for the global research and develo...
dpa-AFX 28.02 GNW-Adhoc: Idorsia and Viatris enter into a significant global research and development collaboratio...
GlobeNewswire 28.02 Idorsia and Viatris enter into a significant global research and development collaboration
dpa-AFX 10.01 GNW-Adhoc: Idorsia presents at the J.P. Morgan Healthcare Conference - Adapting Idorsia for sustaina...
dpa-AFX 03.11.2023 GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been pres...
GlobeNewswire 03.11.2023 New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at th...
dpa-AFX 27.10.2023 Aktien Zürich Schluss: SMI mit erneuten Verlusten zum Wochenschluss
dpa-AFX 24.10.2023 Aktien Zürich Schluss: SMI schließt im Plus - Schwergewicht Novartis stützt